Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
CE-Ventures leads the final close of the $26mln Series A funding round for Exeliom Biosciences to advance pipeline-in-a-drug strategy zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.
Exeliom Biosciences is on a mission to bring innovation to the pharmaceutical treatment of inflammatory bowel diseases, cancer, and infectious diseases